CANbridge Pharmaceuticals (MF1.F) Q3 2025 Earnings

31AugConfirmed
Q1 2024
Q3 2024
Q1 2025
Q3 2025
-0.07
-0.04
-0.01
0.02

Details

Expected EPS
N/A
Actual EPS
0.01671175443
Surprise EPS
0.02
Surprise Percent
+∞%

Description

CANbridge Pharmaceuticals (MF1.F) has reported earnings of 0.01671175443 per share for Q3 2025.

0 Comments

Share your thoughts